Evaluating MOTS-c peptide price requires analyzing per-milligram purity, lot-specific testing, and analytical verification rather than raw retail tags. Research-grade MOTS-c typically reflects manufacturing controls, sequence validation via mass spectrometry, and endotoxin screening. PX1 Research provides fully documented, USA-manufactured MOTS-c for preclinical laboratory research with transparent lot-level certification.
Evaluating MOTS-c peptide price requires analyzing per-milligram purity, lot-specific testing, and analytical verification rather than raw retail tags. Research-grade MOTS-c typically reflects manufacturing controls, sequence validation via mass spectrometry, and endotoxin screening. PX1 Research provides fully documented, USA-manufactured MOTS-c for preclinical laboratory research with transparent lot-level certification.
When assessing the overall MOTS-c peptide price in scientific procurement, laboratory buyers must examine the technical variables that drive manufacturing costs. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. Synthesizing this specific sequence requires precise solid-phase peptide synthesis (SPPS) protocols to prevent truncation, aggregation, or incomplete sequence assembly. Consequently, variations in market pricing usually correlate directly with synthesis purity thresholds, purification steps, and analytical verification.
Primary cost drivers for laboratory-grade peptides include the scale of synthesis, purification rounds via reverse-phase high-performance liquid chromatography (RP-HPLC), and the rigor of quality control testing. Lower-cost products online often omit essential analytical validation steps, such as lot-specific Electrospray Ionization Mass Spectrometry (ESI-MS) or Chromogenic Limulus Amebocyte Lysate (LAL) endotoxin assays. When procuring material for cell culture or animal models, understanding the relationship between MOTS-c peptide price and verifiable purity is essential for ensuring experimental reproducibility. Institutional facilities purchasing in higher quantities can also explore wholesale laboratory accounts to optimize per-vial research budgets without sacrificing chemical fidelity.
MOTS-c belongs to a distinct class of signaling molecules known as mitochondrial-derived peptides (MDPs). Unlike classic nuclear-encoded peptides, MOTS-c is encoded within the short open reading frame (sORF) of the mitochondrial 12S ribosomal RNA gene. This unique genomic origin positions MOTS-c as a key retrograde signal, transferring information from the organelle to the nucleus to modulate nuclear gene expression during metabolic shifts.
In preclinical model systems, MOTS-c has demonstrated systemic signaling capabilities despite its mitochondrial origin. Researchers studying mitochondrial research peptides focus on how MOTS-c translocates to the nucleus under metabolic stress conditions, where it interacts with specific transcription factors like NRF2 and AP-1. Exploring these structural and biological characteristics helps contextualize why specialized synthesis techniques are required, as detailed in the comprehensive PX1 Research catalog.
Preclinical literature demonstrates that MOTS-c plays a crucial regulatory role in cellular energy balance and metabolic adaptation. In vitro assays using skeletal muscle cell lines indicate that MOTS-c activates AMP-activated protein kinase (AMPK), a central controller of cellular energy homeostasis. This activation leads to enhanced glucose uptake, increased fatty acid oxidation, and optimized mitochondrial respiration without altering basal ATP levels.
In animal studies, rodent models subjected to metabolic challenges (such as high-fat diet-induced insulin resistance) exhibited improved metabolic flexibility when treated with synthetic MOTS-c. Furthermore, exercise-capacity research reveals that MOTS-c expression increases endogenously in response to physical exertion. Preclinical models investigating physical performance demonstrate that exogenous MOTS-c administration can enhance exercise capacity, heat tolerance, and systemic energy expenditure. Researchers evaluating in vitro metabolic research protocols rely on high-purity MOTS-c to ensure that metabolic parameter shifts are attributable solely to the peptide target rather than synthesis contaminants.
The primary determinant of peptide pricing integrity is the verification methodology applied post-synthesis. A true research-grade MOTS-c batch must undergo rigorous purification to achieve a target purity of ≥98%. Crude or partially purified peptides (e.g., 80–90% purity) are less costly to produce, but they contain residual peptide fragments, deleted sequences, and counter-ion impurities that obscure assay results.
Analytical evaluation requires two complementary methods: RP-HPLC to establish chemical purity percentages and ESI-MS to confirm absolute molecular weight (1874.3 g/mol for MOTS-c). Facilities conducting high-precision investigations should demand independent validation. Detailed documentation standards, such as those outlined in our overview of HPLC and Mass Spectrometry analysis, highlight why lot-specific Certificates of Analysis (COAs) are vital when evaluating supplier pricing structures.
Bacterial endotoxins (lipopolysaccharides) represent a major source of experimental interference in cell-based assays and animal studies. Residual endotoxins introduced during peptide synthesis or processing can trigger non-specific inflammatory signaling pathways, confounding metabolic and gene expression data. Consequently, comprehensive endotoxin quantification directly impacts the ultimate MOTS-c peptide price.
PX1 Research subjects every production lot to rigorous LAL chromogenic testing to ensure endotoxin levels remain strictly below <0.01 EU/mg. Furthermore, full lot traceability guarantees that every vial shipped from our USA-based storage facilities (located in California and Arizona) can be matched back to its original synthesis run and quality control report. Laboratory managers can review full analytical testing protocols to verify batch compliance prior to experimental deployment.
When designing mitochondrial signaling paradigms, investigators frequently compare MOTS-c against other well-studied peptides targeting organelle function. For instance, while MOTS-c operates primarily as a nuclear-translocating metabolic regulator via AMPK pathways, SS-31 (Bendavia) functions directly within the inner mitochondrial membrane by binding cardiolipin to prevent electron leakage and reduce ROS production. Meanwhile, Humanin—the first discovered mitochondrial-derived peptide—exhibits cytoprotective and anti-apoptotic signaling across neurodegenerative models.
Understanding these mechanistic differences allows laboratories to select the appropriate compound for their specific research vectors. While SS-31 targets structural membrane stabilization and Humanin focuses on cell survival pathways, MOTS-c provides a unique model for metabolic adaptation and gene expression regulation. Evaluating these peptides side-by-side helps clarify their distinct synthesis complexities and relative cost structures within preclinical research.
Proper handling and solubilization are critical to preserving the structural stability of MOTS-c once acquired. MOTS-c is supplied as a lyophilized (freeze-dried) powder to maximize shelf-life. Upon receipt, laboratory personnel should reconstitute the peptide under sterile laminar flow conditions using appropriate solvents based on the intended assay environment.
For standard cell culture and animal models, sterile Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4) is recommended. If reconstitution difficulties arise due to sequence hydrophobicity, brief gentle sonication or the addition of a dilute acetic acid carrier solution (0.1%) may be employed. Researchers preparing working solutions should consult our detailed peptide reconstitution protocols to calculate precise molar concentrations and prevent degradation caused by incorrect handling.
Peptide integrity relies heavily on temperature control during shipping and storage. Lyophilized MOTS-c remains stable at room temperature for brief transit periods, but long-term preservation requires storage at -20°C or -80°C in a desiccated environment. Exposure to moisture, heat, or light can lead to hydrolysis or peptide oxidation.
Once reconstituted, liquid aliquots of MOTS-c should be divided into single-use volumes and stored at -80°C to avoid repeated freeze-thaw cycles, which induce mechanical shearing and protein denaturation. Proper laboratory storage protocols preserve chemical potency, ensuring that trial data remains consistent across multi-week research schedules.
Selecting a research peptide partner requires looking beyond superficial price tags to evaluate supply chain transparency, domestic manufacturing compliance, and testing rigor. Low-cost vendors frequently operate without ISO 17025 accredited analytical verification, risking batch-to-batch variation, improper sequence assembly, or heavy metal contamination.
PX1 Research sets the standard for research peptide distribution across the United States. Manufactured in GMP-compliant facilities and tested by third-party laboratories, our MOTS-c inventory guarantees reproducible chemical characteristics for academic, biotech, and clinical research institutions. Organizations seeking routine supply can access our bulk supply portal to review volume discounts, sample documentation, and same-day dispatch schedules.
What determines the market price of research-grade MOTS-c peptide?
MOTS-c peptide pricing is primarily determined by synthesis scale, sequence complexity (16 amino acids), target purity (>98%), and analytical verification costs. Independent third-party testing—including RP-HPLC purity validation, ESI-MS mass verification, and LAL endotoxin assays—adds operational cost but guarantees experimental accuracy.
Why is third-party COA verification critical when evaluating MOTS-c price?
A third-party Certificate of Analysis (COA) confirms that the product contains the precise molecular weight and purity percentage advertised. Unverified peptides may contain synthesis truncation sequences, residual solvents, or heavy metals that disrupt cell culture assays and invalidate preclinical data.
What primary mechanisms are investigated in MOTS-c research?
In preclinical research, MOTS-c is studied for its role in mitochondrial-nuclear communication, metabolic regulation via AMPK activation, glucose homeostasis, fatty acid oxidation, and exercise-capacity adaptation in animal models.
How should MOTS-c be stored after delivery to the laboratory?
Lyophilized MOTS-c should be stored at -20°C or -80°C in a desiccated container away from light. Once reconstituted, stock solutions should be divided into single-use aliquots and frozen at -80°C to prevent degradation from freeze-thaw cycles.
How does MOTS-c differ from SS-31 in preclinical studies?
While MOTS-c is a mitochondrial-derived signaling peptide that translocates to the nucleus to regulate metabolic genes, SS-31 is a synthetic targeted tetrapeptide that binds cardiolipin in the inner mitochondrial membrane to optimize electron transport and reduce oxidative stress.
What solvent is recommended for reconstituting MOTS-c for in vitro assays?
MOTS-c is typically reconstituted using sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS). Gentle vortexing or brief sonication may be used if required. Reconstitution should always take place under a sterile laminar flow hood.
Can PX1 Research provide bulk or institutional pricing for MOTS-c?
Yes, PX1 Research offers tiered volume pricing and wholesale accounts for academic laboratories, biotechnology firms, and institutional research facilities requiring ongoing bulk supplies of MOTS-c.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.